Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2018.10.052
Abstract: 3. Guy GP Jr, Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC, Centers for Disease Control and Prevention. Vital signs: melanoma incidence and mortality trends and projections — United States, 1982e2030. MMWR Morb… read more here.
Keywords: research; report radar; melanoma subsequent; exposure report ... See more keywords
Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time
Sign Up to like & getrecommendations! Published in 2019 at "Revue Neurologique"
DOI: 10.1016/j.neurol.2019.01.270
Abstract: Introduction Since the 2012 identification of 3 risk factors for natalizumab-associated progressive multifocal leucoencephalopathy (PML) changes in the PML incidence rate have been of interest. Objectives Determine the natalizumab-associated PML incidence in the global postmarketing… read more here.
Keywords: incidence; natalizumab associated; associated progressive; natalizumab exposure ... See more keywords